TrinityPoint Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $5.31M | Buy |
200,195
+8,651
| +5% | +$230K | 0.75% | 28 |
|
2024
Q3 | $5.54M | Buy |
191,544
+88,258
| +85% | +$2.55M | 0.8% | 27 |
|
2024
Q2 | $2.89M | Sell |
103,286
-35,437
| -26% | -$992K | 0.45% | 58 |
|
2024
Q1 | $3.85M | Buy |
138,723
+5,351
| +4% | +$148K | 0.64% | 36 |
|
2023
Q4 | $3.84M | Sell |
133,372
-24,038
| -15% | -$692K | 0.7% | 28 |
|
2023
Q3 | $5.22M | Buy |
157,410
+6,782
| +5% | +$225K | 1.04% | 19 |
|
2023
Q2 | $5.53M | Buy |
150,628
+64,669
| +75% | +$2.37M | 1.08% | 20 |
|
2023
Q1 | $3.51M | Buy |
85,959
+6,727
| +8% | +$274K | 0.75% | 31 |
|
2022
Q4 | $4.06M | Buy |
79,232
+14,967
| +23% | +$767K | 0.92% | 24 |
|
2022
Q3 | $2.81M | Buy |
64,265
+25
| +0% | +$1.09K | 0.64% | 35 |
|
2022
Q2 | $3.37M | Sell |
64,240
-1,140
| -2% | -$59.8K | 0.74% | 31 |
|
2022
Q1 | $3.39M | Buy |
65,380
+273
| +0.4% | +$14.1K | 0.61% | 43 |
|
2021
Q4 | $3.85M | Sell |
65,107
-1,278
| -2% | -$75.5K | 0.68% | 38 |
|
2021
Q3 | $2.86M | Buy |
66,385
+4,127
| +7% | +$177K | 0.55% | 52 |
|
2021
Q2 | $2.44M | Buy |
62,258
+1,589
| +3% | +$62.2K | 0.5% | 52 |
|
2021
Q1 | $2.2M | Sell |
60,669
-56,606
| -48% | -$2.05M | 0.51% | 51 |
|
2020
Q4 | $4.38M | Buy |
117,275
+5,536
| +5% | +$207K | 1.05% | 21 |
|
2020
Q3 | $3.89M | Buy |
111,739
+49,396
| +79% | +$1.72M | 1.08% | 19 |
|
2020
Q2 | $1.93M | Sell |
62,343
-35,535
| -36% | -$1.1M | 0.61% | 43 |
|
2020
Q1 | $3.03M | Buy |
97,878
+34,883
| +55% | +$1.08M | 1.2% | 20 |
|
2019
Q4 | $2.34M | Sell |
62,995
-2,046
| -3% | -$76.1K | 0.79% | 30 |
|
2019
Q3 | $2.35M | Buy |
65,041
+37,293
| +134% | +$1.35M | 0.82% | 30 |
|
2019
Q2 | $1.13M | Sell |
27,748
-862
| -3% | -$35.1K | 0.54% | 49 |
|
2019
Q1 | $1.15M | Buy |
28,610
+6,870
| +32% | +$277K | 0.57% | 53 |
|
2018
Q4 | $900K | Buy |
+21,740
| New | +$900K | 0.55% | 51 |
|